Reported 2026-06-05Lot IPA10-062026-199.77% purity · 11.61 mg
Open COA
Lyophilized Peptides
Ipamorelin 10MG
NNC 26-0161; Aib-His-D-2-Nal-D-Phe-Lys-NH2
A synthetic pentapeptide growth-hormone secretagogue studied as an agonist of growth-hormone secretagogue receptor 1a.
CatalogIPA-PW-10MG
ManufacturerRemetide
PurityTarget ≥99% by RP-HPLC; lot result controls
Pack10 mg
$65.00 — or Original price was: $65.00.$55.25Current price is: $55.25. / month Current catalog price; lot availability controls fulfillment.
AvailabilityIn stock
6296 in stock
Subscribe monthly and save 15%$55.25 per delivery. The same price applies to the first order and recurring renewals.
- Guest checkout
- All major cards
- COA per lot
- 2-day shipping
- Cancel anytime
Ipamorelin 10MG$65.00COA available
01Lot documentationCOA and analytical-record model
02Defined specificationMethod and result remain lot specific
03Tracked fulfillmentShipping method and lot allocation confirmed at order review
04Responsible useNon-clinical laboratory context
Lot documentation
Current Certificate of Analysis
11 approved certificates are attached to this product record.
Reported 2026-05-29Lot IPA10-052026-499.95% purity · 12.05 mg
Open COA
Reported 2026-05-14Lot IPA10-052026-799.90% purity · 11.41 mg
Open COA
View all historical COAs (8)
Reported 2026-03-18Lot IPA 10-032026-199.71% purity · 11.58 mg
Open COA
Reported 2026-02-27Lot IPA10-02242026-J99.66% purity · 9.36 mg
Open COA
Reported 2026-02-05Lot IPA0128206-199.947% purity · 12.97 mg
Open COA
Reported 2025-12-11Lot IPA12092025-J99.838% purity · 13.29 mg
Open COA
Reported 2025-12-04Lot IPA12012025-J99.957% purity · 12.90 mg
Open COA
Reported 2025-10-11Lot IPA1008282025-1098.551% purity · 9.88 mg
Open COA
Reported 2025-09-10Lot IPA09032025-J99.81% purity · 9.87 mg
Open COA
Reported 2025-06-15Lot N-IPA100611 2025-0999.5% purity · 9.98 mg
Open COA
Technical information
Chemical & material record
Presented in a scientific-catalog format so the material can be evaluated by identity, form and documentation before purchase.
- Identity
- Ipamorelin research peptide; salt form controlled by the approved specification
- Synonyms
- NNC 26-0161; Aib-His-D-2-Nal-D-Phe-Lys-NH2
- CAS number
- See approved salt-form specification
- Molecular formula
- See approved Remetide material specification
- Formula weight
- See approved Remetide material specification
- Sequence / identity note
- Aib-His-D-2-Nal-D-Phe-Lys-NH2; salt form controlled in the technical record
- Manufacturer
- Remetide
- Manufacturing role
- Custom peptide synthesis and manufacture
- Form
- Lyophilized, non-sterile research material
- Purity specification
- Target ≥99% by RP-HPLC; lot result controls
- Storage
- -20°C, dry and protected from light; follow lot documentation
- Pack size
- 10 mg
- Catalog number
- IPA-PW-10MG
Research context
Published research & product context
Published literature is presented separately from lot-specific identity, purity and analytical results.
Ipamorelin (NNC 26-0161) is a synthetic pentapeptide growth-hormone secretagogue. Published receptor studies characterize binding and signaling at growth-hormone secretagogue receptor 1a (GHS-R1a), along with growth-hormone release in primary rat pituitary cells.
Reported values include a Ki of 63.4 nM in GHS-R1a-expressing COS-7 cells, an IP3-accumulation EC50 of 46.9 nM in receptor-expressing BHK cells and a growth-hormone-release EC50 of 1.3 nM in primary rat pituitary cells. Assay design and material form can affect observed values.
Selected published findings
- Bound GHS-R1a in a receptor-expressing COS-7 cellular system.
- Induced IP3 accumulation in GHS-R1a-expressing BHK cells.
- Induced growth-hormone release in primary rat pituitary cells.
References and product citations 2
- Hansen, B.S., Raun, K., Nielsen, K.K., et al. Pharmacological characterisation of a new oral GH secretagogue, ipamorelin. European Journal of Endocrinology 141(2), 180–189 (1999).
- Raun, K., Hansen, B.S., Johansen, N.L., et al. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology 139(5), 552–561 (1998).
Literature interpretation: This summary describes published experimental literature and is not a lot specification, clinical claim, use instruction or representation that the supplied research material will reproduce a published result. This record intentionally excludes dosing, administration, clinical outcomes, patient eligibility and therapeutic comparisons.
Intended laboratory context
Illustrative applications
- Analytical comparison
- Method development
- In-vitro laboratory investigation
- Research protocol development
Documentation package
Documentation
- PDFCertificate of AnalysisSample
- PDFHPLC chromatogramSample
- PDFMass-spectrometry summarySample
- PDFHandling statementSample
For laboratory research workflows only. Not for administration to humans or animals and not supplied with dosing or reconstitution guidance.
FAQ
Research procurement FAQ
Plain answers about research-use boundaries, documentation, accounts, and ordering. Not medical or clinical guidance.
What is this product record for?
Ipamorelin 10MG is presented as a research catalog record with identity, format, pack options, specification language, and lot-documentation pathways for qualified laboratory procurement. It is not a consumer or clinical product.
How do I order this item?
Open the product record, choose the pack option, and check out as a guest (no account needed) or signed in. If the item is quotation-only (bulk API or custom project), use the quotation pathway instead of standard cart checkout.
What does “research use only” mean?
Research use only (RUO) means these materials are intended for legitimate non-clinical laboratory investigation. They are not offered for human or animal administration, compounding, diagnosis, treatment, prevention, or consumer use.
Do I need an account to browse or buy?
No. Guest checkout is open: you can browse the catalog and order without creating an account. Subscribe & Save orders get an account created automatically so you can manage or cancel the subscription. Lot documentation stays tied to every order either way.
What documentation accompanies a research material?
Lot-level documentation may include a Certificate of Analysis (COA), identity/purity method context, and related analytical records. Always defer to the approved lot record and material specification for the specific shipment.
How is purity described?
Purity statements identify the analytical method (for example RP-HPLC) and defer to the released lot result and any molecule-specific specification. Public copy never replaces the lot COA.
How does shipping work for research materials?
Shipping follows the carrier and packaging appropriate for the material specification. Inspect shipments promptly and contact support with the order number, catalog number, and lot if anything looks incorrect. Unauthorized returns of research materials are not accepted.
Does Simple Life Science provide dosing or medical guidance?
No. We do not provide dosing, administration, medical advice, patient selection, or clinical-use instructions. Website content and technical support stay within laboratory research context.
Need a current record?
Documentation before decision-making.
Reference IPA-PW-10MG and the applicable lot when contacting technical support. Published files support evaluation but do not replace the approved lot COA or material specification.
View documentation model
